NCT03641105

Brief Summary

Detect the contents of glucose metabolism molecules in the tumor and adjacent normal samples of about 100 patients with lung adenocarcinoma using mass spectroscopy. Analyze the correlation between the contents and the clinicopathological characteristics and survival.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2014

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
4.6 years until next milestone

First Submitted

Initial submission to the registry

August 18, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 21, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

August 21, 2018

Status Verified

August 1, 2018

Enrollment Period

5.2 years

First QC Date

August 18, 2018

Last Update Submit

August 18, 2018

Conditions

Lung CancerGlycolysisDiagnosisSurvival

Outcome Measures

Primary Outcomes (1)

  • disease-free survival

    disease-free survival

    1 month

Secondary Outcomes (1)

  • overall survival

    1 month

Study Arms (1)

lung adenocarcinoma

patients with lung adenocarcinoma

Diagnostic Test: Diagnostic test

Interventions

Diagnostic testDIAGNOSTIC_TEST

detect the contents of glucose metabolism molecules using mass spectrum

lung adenocarcinoma

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with primary lung adenocarcinoma

You may qualify if:

  • Primary lung adenocarcinoma

You may not qualify if:

  • Other tumor histories, received radiotherapy or chemotherapy before surgery, tumor or adjacent normal tissues can't be obtained, patient rejected.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lung NeoplasmsDisease

Interventions

Diagnostic Tests, Routine

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2018

First Posted

August 21, 2018

Study Start

January 1, 2014

Primary Completion

March 1, 2019

Study Completion

March 1, 2019

Last Updated

August 21, 2018

Record last verified: 2018-08